# Trade Mark Journal No.2026/024 12 June 2026

## UK00004393428 27 May 2026 (5,10)

BONEPACE

International priority date claimed: 19 February 2026 (European Union Intellectual Property Office (EUIPO)) (19319267)

Class 5
  Veterinary preparations; Medical preparations; Pharmaceuticals; Sanitary preparations for medical purposes; Bone cements for surgical purposes; Bone cements for orthopaedic purposes; Bone cement for medical purposes; Bone void fillers consisting of natural materials; Bone void fillers comprised of living tissues; Bone fillers consisting of living materials; Bone cement for surgical and orthopaedic purposes; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of bone diseases; Synthetic material for use in setting bones; Bone growth media consisting of biological materials for medical purposes; Anti-bacterial preparations; Antiseptics; Antiseptics with prophylactic effect; Antiseptics with therapeutic effect; Bactericides; Disinfectants; Disinfectants for medical use; Germicides; Germicidal preparations [other than soap]; Sterilising substances; Sterilizing preparations; Anti-inflammatory preparations; Antibiotics; Pharmaceutical preparations; Pain relief preparations; Biological implants.
Class 10
  Veterinary apparatus and instruments; Surgical apparatus and instruments; Dental apparatus and instruments; Medical apparatus and instruments; Artificial limbs; Artificial teeth; Artificial eyes; Bone substitutes for surgical use; Bone implants composed of artificial materials; Bone void fillers comprised of artificial materials; Bone prostheses; Osseous implants; Bone graft substitutes; Artificial bone materials; Implants [prosthesis] for bone surgery; Biodegradable bone fixation implants; Implants [prosthesis] for use in bone grafting; Applicators for pharmaceutical preparations; Applicators for antibacterial preparations.

Heraeus Medical GmbH

Representative: Baron Warren Redfern LLP